• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOT

BOTANIX PHARMACEUTICALS LTD - Announcements

1.61% ! 15.3¢
Market Cap $303.9M  !

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

Announcements



BOT Results of Meeting26/10/21 download Created with Sketch. 129.67KB
BOT Investor Presentation - Annual General meeting26/10/21 download Created with Sketch. 2.35MB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE25/10/21 download Created with Sketch. 360.92KB
BOT Notification regarding unquoted securities - BOT08/10/21 download Created with Sketch. 28.22KB
BOT Canine Atopic Dermatitis Program LaunchedPRICE SENSITIVE29/09/21 download Created with Sketch. 202.24KB
BOT Botanix Expands Management Team24/09/21 download Created with Sketch. 165.15KB
BOT Letter to Shareholders - Annual General Meeting20/09/21 download Created with Sketch. 181.04KB
BOT Notice of Annual General Meeting/Proxy Form20/09/21 download Created with Sketch. 887.7KB
BOT Botanix Presentation Corporate Update01/09/21 download Created with Sketch. 4.8MB
BOT Final Report and Annual Report to ShareholdersPRICE SENSITIVE27/08/21 download Created with Sketch. 1.27MB
BOT Apendix 4G27/08/21 download Created with Sketch. 282.45KB
BOT Annual General Meeting27/08/21 download Created with Sketch. 118.39KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE23/07/21 download Created with Sketch. 426.55KB
BOT New Canine Pilot Study Supports Further AD InvestigationPRICE SENSITIVE17/05/21 download Created with Sketch. 825.94KB
BOT Updated Investor Presentation and Conference Call05/05/21 download Created with Sketch. 2.03MB
BOT Botanix Update on BTX 1801 Clinical DevelopmentPRICE SENSITIVE04/05/21 download Created with Sketch. 4.66MB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/04/21 download Created with Sketch. 377.91KB
BOT Publication and Awareness boosts BOT Antimicrobial Platform27/04/21 download Created with Sketch. 550.09KB
BOT BTX 1702 Rosacea Study ApprovalPRICE SENSITIVE30/03/21 download Created with Sketch. 200.44KB
BOT Botanix Presenting at ASX Small and Mid-Cap Conference16/03/21 download Created with Sketch. 1.17MB
BOT Final Director's Interest Notice03/03/21 download Created with Sketch. 202.76KB
BOT Botanix Expands Management Team01/03/21 download Created with Sketch. 148.7KB
BOT Half Yearly Report and AccountsPRICE SENSITIVE26/02/21 download Created with Sketch. 730.63KB
BOT Presentation - Dermatology Drug Development Summit Europe19/02/21 download Created with Sketch. 4MB
BOT Botanix receives A$6.87m R&D Tax Incentive RefundPRICE SENSITIVE12/02/21 download Created with Sketch. 191.46KB
BOT Phase 2a Study Shows BTX 1801 Eradicates S. AureusPRICE SENSITIVE03/02/21 download Created with Sketch. 233.38KB
BOT Trading HaltPRICE SENSITIVE01/02/21 download Created with Sketch. 556.72KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE22/01/21 download Created with Sketch. 319.75KB
BOT Antimicrobial Data Published in Peer-Reviewed JournalPRICE SENSITIVE20/01/21 download Created with Sketch. 389.41KB
BOT Appendix 2A and Notice Under Section 708A17/12/20 download Created with Sketch. 275.57KB
BOT Update on BTX 1801 Phase 2a Clinical StudyPRICE SENSITIVE14/12/20 download Created with Sketch. 170.19KB
BOT Results of Meeting23/11/20 download Created with Sketch. 123.72KB
BOT AGM Presentation23/11/20 download Created with Sketch. 2.17MB
BOT FDA Clears Development Path for BTX 1801PRICE SENSITIVE11/11/20 download Created with Sketch. 192.92KB
BOT Letter to Shareholders - AGM21/10/20 download Created with Sketch. 830.41KB
BOT Notice of Annual General Meeting/Proxy Form21/10/20 download Created with Sketch. 947.75KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE13/10/20 download Created with Sketch. 355.44KB
BOT Response to ASX Price QueryPRICE SENSITIVE29/09/20 download Created with Sketch. 708.96KB
BOT New Antimicrobial Data and Conference PresentationPRICE SENSITIVE08/09/20 download Created with Sketch. 1.73MB
BOT Annual Report to Shareholders with Revised Top 2008/09/20 download Created with Sketch. 872.2KB
BOT Appendix 4G31/08/20 download Created with Sketch. 180.98KB
BOT Appendix 4E and Annual Report to ShareholdersPRICE SENSITIVE31/08/20 download Created with Sketch. 1.01MB
BOT BTX 1801 Phase 2a Antimicrobial Study UnderwayPRICE SENSITIVE12/08/20 download Created with Sketch. 187.59KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/07/20 download Created with Sketch. 326.32KB
BOT Response to ASX Aware QueryPRICE SENSITIVE22/07/20 download Created with Sketch. 740.97KB
BOT BTX 1503 End of Phase 2 Milestone with FDAPRICE SENSITIVE17/07/20 download Created with Sketch. 160.69KB
BOT Change of Director's Interest Notice * 401/07/20 download Created with Sketch. 375.4KB
BOT Appendix 3G01/07/20 download Created with Sketch. 296.4KB
BOT Amended Constitution24/06/20 download Created with Sketch. 936.39KB
BOT Results of Meeting24/06/20 download Created with Sketch. 135.85KB
BOT Botanix Provides Update on Development Activities24/06/20 download Created with Sketch. 160.4KB
BOT Letter to Shareholders - General Meeting22/05/20 download Created with Sketch. 835.97KB
BOT Notice of General Meeting/Proxy Form22/05/20 download Created with Sketch. 1.02MB
BOT Change of Director's Interest Notice MT11/05/20 download Created with Sketch. 190.94KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/04/20 download Created with Sketch. 303.6KB
BOT FDA Grants BTX 1801 QIDP Designation StatusPRICE SENSITIVE24/04/20 download Created with Sketch. 275.59KB
BOT Proposed issue of Securities - BOT16/04/20 download Created with Sketch. 27.27KB
BOT Botanix Provides Update on Development Activities AmendedPRICE SENSITIVE16/04/20 download Created with Sketch. 300.12KB
BOT Botanix Provides Update on Development ActivitiesPRICE SENSITIVE16/04/20 download Created with Sketch. 243.29KB
BOT Botanix Announces Top Line BTX 1204 Atopic Dermatitis DataPRICE SENSITIVE25/03/20 download Created with Sketch. 218.13KB
BOT Trading HaltPRICE SENSITIVE24/03/20 download Created with Sketch. 215.48KB
BOT Antimicrobial Platform Update and Launch of BTX 1801 StudyPRICE SENSITIVE13/03/20 download Created with Sketch. 5.77MB
BOT Cowen Conference and Additional BTX 1503 Data Analysis04/03/20 download Created with Sketch. 2.44MB
BOT Half Yearly Report and AccountsPRICE SENSITIVE28/02/20 download Created with Sketch. 925.03KB
BOT Change of Director's Interest Notice SW25/02/20 download Created with Sketch. 217.4KB
BOT Final Director's Interest Notice RT11/02/20 download Created with Sketch. 201.64KB
BOT Initial Director's Interest Notice MC11/02/20 download Created with Sketch. 132.07KB
BOT Botanix Board Update11/02/20 download Created with Sketch. 130.98KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 380KB
BOT Botanix receives A$7.6m R&D Tax Incentive refund29/01/20 download Created with Sketch. 155.59KB
BOT Botanix Attends USA Healthcare Conferences13/01/20 download Created with Sketch. 1.42MB
BOT Change of Director's Interest Notice RT23/12/19 download Created with Sketch. 393.79KB
BOT Change in substantial holding17/12/19 download Created with Sketch. 595.06KB
BOT Interview Botanix Corporate Update16/12/19 download Created with Sketch. 127.46KB
BOT Change of Director's Interest Notice MT10/12/19 download Created with Sketch. 192.87KB
BOT Appendix 2A and Notice Under Section 708A10/12/19 download Created with Sketch. 316.17KB
BOT Investor Presentation09/12/19 download Created with Sketch. 2.29MB
BOT Botanix Initiates BTX 1702 Rosacea StudyPRICE SENSITIVE09/12/19 download Created with Sketch. 160.86KB
BOT Change of Director's Interest Notice RT03/12/19 download Created with Sketch. 239.25KB
BOT Change of Director's Interest Notice BB03/12/19 download Created with Sketch. 253.1KB
BOT Appendix 2A and Notice Under Section 708A02/12/19 download Created with Sketch. 281.08KB
BOT Botanix Announces De-scheduling of Synthetic CBDPRICE SENSITIVE25/11/19 download Created with Sketch. 505.76KB
BOT Botanix presents at Dermatology Drug Development Summit21/11/19 download Created with Sketch. 2.33MB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/10/19 download Created with Sketch. 382.3KB
BOT Results of Meeting28/10/19 download Created with Sketch. 137KB
BOT Annual General Meeting Presentation28/10/19 download Created with Sketch. 2.09MB
BOT BTX 1503 Acne Phase 2 Study Results Presentation23/10/19 download Created with Sketch. 943.69KB
BOT Botanix Announces BTX 1503 Data and Progression to Phase 3PRICE SENSITIVE22/10/19 download Created with Sketch. 739.31KB
BOT Trading HaltPRICE SENSITIVE22/10/19 download Created with Sketch. 359.17KB
BOT Botanix Announces Cannabidiol Supply Agreement with Purisy21/10/19 download Created with Sketch. 532.67KB
BOT BOT Receives Grant for Synthetic Cannabidiol Analog ProgramPRICE SENSITIVE15/10/19 download Created with Sketch. 722.19KB
BOT Notice of Annual General Meeting/Proxy Form27/09/19 download Created with Sketch. 1.13MB
BOT Botanix Investor Presentation17/09/19 download Created with Sketch. 1.76MB
BOT Botanix announces new clinical program to target rosaceaPRICE SENSITIVE16/09/19 download Created with Sketch. 898.27KB
BOT Botanix Presents at International Cannabinoid Summit13/09/19 download Created with Sketch. 2.22MB
BOT Appendix 3B12/09/19 download Created with Sketch. 725.43KB
BOT BOT antimicrobial data presented at ASM-ESCMID Conference06/09/19 download Created with Sketch. 236.03KB
BOT Appendix 3B04/09/19 download Created with Sketch. 286.85KB
BOT Final Director's Interest Notice MC26/08/19 download Created with Sketch. 198.77KB
BOT Director Temporary Leave of Absence23/08/19 download Created with Sketch. 197.65KB
BOT Results of Meeting
26/10/21 download Created with Sketch. 129.67KB
BOT Investor Presentation - Annual General meeting
26/10/21 download Created with Sketch. 2.35MB
BOT Appendix 4C - Quarterly
25/10/21PRICE SENSITIVE download Created with Sketch. 360.92KB
BOT Notification regarding unquoted securities - BOT
08/10/21 download Created with Sketch. 28.22KB
BOT Canine Atopic Dermatitis Program Launched
29/09/21PRICE SENSITIVE download Created with Sketch. 202.24KB
BOT Botanix Expands Management Team
24/09/21 download Created with Sketch. 165.15KB
BOT Letter to Shareholders - Annual General Meeting
20/09/21 download Created with Sketch. 181.04KB
BOT Notice of Annual General Meeting/Proxy Form
20/09/21 download Created with Sketch. 887.7KB
BOT Botanix Presentation Corporate Update
01/09/21 download Created with Sketch. 4.8MB
BOT Final Report and Annual Report to Shareholders
27/08/21PRICE SENSITIVE download Created with Sketch. 1.27MB
BOT Apendix 4G
27/08/21 download Created with Sketch. 282.45KB
BOT Annual General Meeting
27/08/21 download Created with Sketch. 118.39KB
BOT Appendix 4C - Quarterly
23/07/21PRICE SENSITIVE download Created with Sketch. 426.55KB
BOT New Canine Pilot Study Supports Further AD Investigation
17/05/21PRICE SENSITIVE download Created with Sketch. 825.94KB
BOT Updated Investor Presentation and Conference Call
05/05/21 download Created with Sketch. 2.03MB
BOT Botanix Update on BTX 1801 Clinical Development
04/05/21PRICE SENSITIVE download Created with Sketch. 4.66MB
BOT Appendix 4C - Quarterly
30/04/21PRICE SENSITIVE download Created with Sketch. 377.91KB
BOT Publication and Awareness boosts BOT Antimicrobial Platform
27/04/21 download Created with Sketch. 550.09KB
BOT BTX 1702 Rosacea Study Approval
30/03/21PRICE SENSITIVE download Created with Sketch. 200.44KB
BOT Botanix Presenting at ASX Small and Mid-Cap Conference
16/03/21 download Created with Sketch. 1.17MB
BOT Final Director's Interest Notice
03/03/21 download Created with Sketch. 202.76KB
BOT Botanix Expands Management Team
01/03/21 download Created with Sketch. 148.7KB
BOT Half Yearly Report and Accounts
26/02/21PRICE SENSITIVE download Created with Sketch. 730.63KB
BOT Presentation - Dermatology Drug Development Summit Europe
19/02/21 download Created with Sketch. 4MB
BOT Botanix receives A$6.87m R&D Tax Incentive Refund
12/02/21PRICE SENSITIVE download Created with Sketch. 191.46KB
BOT Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
03/02/21PRICE SENSITIVE download Created with Sketch. 233.38KB
BOT Trading Halt
01/02/21PRICE SENSITIVE download Created with Sketch. 556.72KB
BOT Appendix 4C - Quarterly
22/01/21PRICE SENSITIVE download Created with Sketch. 319.75KB
BOT Antimicrobial Data Published in Peer-Reviewed Journal
20/01/21PRICE SENSITIVE download Created with Sketch. 389.41KB
BOT Appendix 2A and Notice Under Section 708A
17/12/20 download Created with Sketch. 275.57KB
BOT Update on BTX 1801 Phase 2a Clinical Study
14/12/20PRICE SENSITIVE download Created with Sketch. 170.19KB
BOT Results of Meeting
23/11/20 download Created with Sketch. 123.72KB
BOT AGM Presentation
23/11/20 download Created with Sketch. 2.17MB
BOT FDA Clears Development Path for BTX 1801
11/11/20PRICE SENSITIVE download Created with Sketch. 192.92KB
BOT Letter to Shareholders - AGM
21/10/20 download Created with Sketch. 830.41KB
BOT Notice of Annual General Meeting/Proxy Form
21/10/20 download Created with Sketch. 947.75KB
BOT Appendix 4C - Quarterly
13/10/20PRICE SENSITIVE download Created with Sketch. 355.44KB
BOT Response to ASX Price Query
29/09/20PRICE SENSITIVE download Created with Sketch. 708.96KB
BOT New Antimicrobial Data and Conference Presentation
08/09/20PRICE SENSITIVE download Created with Sketch. 1.73MB
BOT Annual Report to Shareholders with Revised Top 20
08/09/20 download Created with Sketch. 872.2KB
BOT Appendix 4G
31/08/20 download Created with Sketch. 180.98KB
BOT Appendix 4E and Annual Report to Shareholders
31/08/20PRICE SENSITIVE download Created with Sketch. 1.01MB
BOT BTX 1801 Phase 2a Antimicrobial Study Underway
12/08/20PRICE SENSITIVE download Created with Sketch. 187.59KB
BOT Appendix 4C - Quarterly
30/07/20PRICE SENSITIVE download Created with Sketch. 326.32KB
BOT Response to ASX Aware Query
22/07/20PRICE SENSITIVE download Created with Sketch. 740.97KB
BOT BTX 1503 End of Phase 2 Milestone with FDA
17/07/20PRICE SENSITIVE download Created with Sketch. 160.69KB
BOT Change of Director's Interest Notice * 4
01/07/20 download Created with Sketch. 375.4KB
BOT Appendix 3G
01/07/20 download Created with Sketch. 296.4KB
BOT Amended Constitution
24/06/20 download Created with Sketch. 936.39KB
BOT Results of Meeting
24/06/20 download Created with Sketch. 135.85KB
BOT Botanix Provides Update on Development Activities
24/06/20 download Created with Sketch. 160.4KB
BOT Letter to Shareholders - General Meeting
22/05/20 download Created with Sketch. 835.97KB
BOT Notice of General Meeting/Proxy Form
22/05/20 download Created with Sketch. 1.02MB
BOT Change of Director's Interest Notice MT
11/05/20 download Created with Sketch. 190.94KB
BOT Appendix 4C - Quarterly
30/04/20PRICE SENSITIVE download Created with Sketch. 303.6KB
BOT FDA Grants BTX 1801 QIDP Designation Status
24/04/20PRICE SENSITIVE download Created with Sketch. 275.59KB
BOT Proposed issue of Securities - BOT
16/04/20 download Created with Sketch. 27.27KB
BOT Botanix Provides Update on Development Activities Amended
16/04/20PRICE SENSITIVE download Created with Sketch. 300.12KB
BOT Botanix Provides Update on Development Activities
16/04/20PRICE SENSITIVE download Created with Sketch. 243.29KB
BOT Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data
25/03/20PRICE SENSITIVE download Created with Sketch. 218.13KB
BOT Trading Halt
24/03/20PRICE SENSITIVE download Created with Sketch. 215.48KB
BOT Antimicrobial Platform Update and Launch of BTX 1801 Study
13/03/20PRICE SENSITIVE download Created with Sketch. 5.77MB
BOT Cowen Conference and Additional BTX 1503 Data Analysis
04/03/20 download Created with Sketch. 2.44MB
BOT Half Yearly Report and Accounts
28/02/20PRICE SENSITIVE download Created with Sketch. 925.03KB
BOT Change of Director's Interest Notice SW
25/02/20 download Created with Sketch. 217.4KB
BOT Final Director's Interest Notice RT
11/02/20 download Created with Sketch. 201.64KB
BOT Initial Director's Interest Notice MC
11/02/20 download Created with Sketch. 132.07KB
BOT Botanix Board Update
11/02/20 download Created with Sketch. 130.98KB
BOT Appendix 4C - Quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 380KB
BOT Botanix receives A$7.6m R&D Tax Incentive refund
29/01/20 download Created with Sketch. 155.59KB
BOT Botanix Attends USA Healthcare Conferences
13/01/20 download Created with Sketch. 1.42MB
BOT Change of Director's Interest Notice RT
23/12/19 download Created with Sketch. 393.79KB
BOT Change in substantial holding
17/12/19 download Created with Sketch. 595.06KB
BOT Interview Botanix Corporate Update
16/12/19 download Created with Sketch. 127.46KB
BOT Change of Director's Interest Notice MT
10/12/19 download Created with Sketch. 192.87KB
BOT Appendix 2A and Notice Under Section 708A
10/12/19 download Created with Sketch. 316.17KB
BOT Investor Presentation
09/12/19 download Created with Sketch. 2.29MB
BOT Botanix Initiates BTX 1702 Rosacea Study
09/12/19PRICE SENSITIVE download Created with Sketch. 160.86KB
BOT Change of Director's Interest Notice RT
03/12/19 download Created with Sketch. 239.25KB
BOT Change of Director's Interest Notice BB
03/12/19 download Created with Sketch. 253.1KB
BOT Appendix 2A and Notice Under Section 708A
02/12/19 download Created with Sketch. 281.08KB
BOT Botanix Announces De-scheduling of Synthetic CBD
25/11/19PRICE SENSITIVE download Created with Sketch. 505.76KB
BOT Botanix presents at Dermatology Drug Development Summit
21/11/19 download Created with Sketch. 2.33MB
BOT Appendix 4C - Quarterly
31/10/19PRICE SENSITIVE download Created with Sketch. 382.3KB
BOT Results of Meeting
28/10/19 download Created with Sketch. 137KB
BOT Annual General Meeting Presentation
28/10/19 download Created with Sketch. 2.09MB
BOT BTX 1503 Acne Phase 2 Study Results Presentation
23/10/19 download Created with Sketch. 943.69KB
BOT Botanix Announces BTX 1503 Data and Progression to Phase 3
22/10/19PRICE SENSITIVE download Created with Sketch. 739.31KB
BOT Trading Halt
22/10/19PRICE SENSITIVE download Created with Sketch. 359.17KB
BOT Botanix Announces Cannabidiol Supply Agreement with Purisy
21/10/19 download Created with Sketch. 532.67KB
BOT BOT Receives Grant for Synthetic Cannabidiol Analog Program
15/10/19PRICE SENSITIVE download Created with Sketch. 722.19KB
BOT Notice of Annual General Meeting/Proxy Form
27/09/19 download Created with Sketch. 1.13MB
BOT Botanix Investor Presentation
17/09/19 download Created with Sketch. 1.76MB
BOT Botanix announces new clinical program to target rosacea
16/09/19PRICE SENSITIVE download Created with Sketch. 898.27KB
BOT Botanix Presents at International Cannabinoid Summit
13/09/19 download Created with Sketch. 2.22MB
BOT Appendix 3B
12/09/19 download Created with Sketch. 725.43KB
BOT BOT antimicrobial data presented at ASM-ESCMID Conference
06/09/19 download Created with Sketch. 236.03KB
BOT Appendix 3B
04/09/19 download Created with Sketch. 286.85KB
BOT Final Director's Interest Notice MC
26/08/19 download Created with Sketch. 198.77KB
BOT Director Temporary Leave of Absence
23/08/19 download Created with Sketch. 197.65KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
15.3¢
Change
-0.003(1.61%)
Mkt cap ! $303.9M
Open High Low Value Volume
15.5¢ 15.5¢ 15.0¢ $113.2K 732.5K

Buyers (Bids)

No. Vol. Price($)
77 3318487 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 3212670 23
View Market Depth
Last trade - 10.23am 31/07/2025 (20 minute delay) ?
Last
15.0¢
  Change
-0.003 ( 4.76 %)
Open High Low Volume
15.3¢ 15.5¢ 14.5¢ 414236
Last updated 10.43am 31/07/2025 ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.